UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 13, 2014
Accession Number:
Submission Type:
CIK: 0001388320
Company Name: Actinium Pharmaceuticals, Inc.
File Number: 333-193714